When health secretary Frank Dobson issued the National Institute for Clinical Excellence with its first two years' work programme recently, the list of drugs to be reviewed included a number which have yet to see the inside of an NHS doctor's surgery.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here